Houston Research Institute ( Site 0221) — Houston, Texas

Houston Research Institute ( Site 0221) is a clinical research site located in Houston, Texas, United States 77079.

Crixeo Health Trust Score: 57/100 (POOR). This profile has not yet been claimed by the site owner.

Houston Research Institute ( Site 0221) has participated in 1 clinical trials.

Therapeutic areas: Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 57/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Houston Research Institute ( Site 0221)?

Houston Research Institute ( Site 0221) has a Crixeo Trust Score of 57/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Houston Research Institute ( Site 0221) conducted?

Houston Research Institute ( Site 0221) has 1 clinical trials on record. Their work covers Metabolic Dysfunction-Associated Steatotic Liver Disease, Non-alcoholic Fatty Liver Disease, Nonalcoholic Fatty Liver Disease.

Is Houston Research Institute ( Site 0221) accredited by Crixeo Health?

Houston Research Institute ( Site 0221) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Houston Research Institute ( Site 0221)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.